More neuromodulation options mean more opportunities to personalize care. In this episode, Dr. Ken Peters and Dr. Tracey Wilson join Dr. Jannah Thompson to discuss the latest implantable tibial nerve stimulation and sacral neuromodulation technologies for OAB and UUI. They compare available devices, share practical insights on patient selection, and explore how shared decision making, advanced practice providers, and equitable access influence treatment adoption.

---

Get the BackTable app
https://www.backtable.com/app

---

This podcast was developed in collaboration with

Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)

https://sufuorg.com/home.aspx

---

Timestamps

00:00 - Introduction
07:59 - Overview of Nerve Stimulation Therapies
13:22 - Case #1
22:00 - Case #2
28:23 - Nuspera
34:21 - APPs in Practice
39:21 - Reimbursement Roadblocks
47:03 - Multimodal Therapy
49:51 - Case #3
56:06 - Final Advice

---

Resources

Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial
https://www.auajournals.org/doi/10.1016/j.juro.2009.12.036

Neuspera Medical Announces 12-Month Pivotal Trial Results for the Company’s Integrated Sacral Neuromodulation System for Urinary Urge Incontinence
https://neuspera.com/neuspera-medical-announces-12-month-pivotal-trial-results-for-the-companys-integrated-sacral-neuromodulation-system-for-urinary-urge-incontinence/

Racial and Socioeconomic Factors Influence Utilization of Advanced Therapies in Commercially Insured OAB Patients: An Analysis of Over 800,000 OAB Patients
https://www.sciencedirect.com/science/article/pii/S0090429520305574?via%3Dihub

---

BackTable Urology is the go-to podcast for urologists, urologic oncologists, and urogynecologists.

Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty.

► https://www.backtable.com/app